MedGraph - Rubie TM

Accelerating Drug Repurposing With AI-Driven Precision

AI-powered drug repurposing platform that integrates knowledge graphs, docking simulations & ML to identify novel drug-target interactions. With extensive compound screening capabilities, it enhances lead identification and optimization for faster, more effective therapeutic discovery

MedGraph-Rubie

Why Choose MedGraph -
Rubie TM

Revolutionizing Drug Repurposing With Data & AI

10M+Compounds
Comprehensive Screening

Comprehensive Screening

Screen FDA-approved, investigational and PubChem/ChEMBL compounds against target proteins

99.9%Accuracy
Knowledge Graph Insights

Knowledge Graph Insights

Leverage structured data repositories to uncover drug repositioning opportunities

100xFaster
AI-Driven Docking

AI-Driven
Docking

Advanced computational docking algorithms ensure precision in lead identification

95%Precision
FEP-Enabled Optimization

FEP-Enabled Optimization

Free Energy Perturbation (FEP) simulations provide atomic-level accuracy for binding affinity predictions

24/7Availability
Scalable and High-Performance

Scalable and High-Performance

HPC-parallel computing allows efficient large-scale screening for novel drug-target interactions

Core Features

Smart, Scalable & AI-Powered Drug Discovery

Knowledge Graph-Based Discovery

Integrates biological databases and extracts meaningful insights using AI to predict new drug applications and repositioning opportunities.

Knowledge Graph-Based Discovery

Integrates FDA-approved drugs, clinical trial data, and research literature

AI-powered extraction of meaningful insights

Predicts new drug applications and repositioning opportunities

Multiple Screening Libraries

Expanding the Scope of Drug Discovery Through Diverse Compound Libraries

FDA-Approved Drug Library

FDA-Approved Drug Library

A curated collection of drugs already approved for human use, allowing for rapid clinical translation

Investigational Drug Library

Investigational Drug Library

Includes experimental compounds in clinical trials with known pharmacokinetic and safety profiles

PubChem & ChEMBL Compound Libraries

PubChem & ChEMBL Compound Libraries

Publicly available chemical repositories containing millions of bioactive molecules

Custom Screening Libraries

Custom Screening Libraries

Users can input proprietary or selected compound sets for specialized screening applications

Databases Used in MedGraph - RubieTM

DrugBank

A comprehensive resource containing chemical, pharmacological, and clinical data on drugs.

ClinicalTrials.gov

Provides real-time insights into ongoing and completed clinical trials, linking investigational drugs to diseases.

BindingDB

Contains measured binding affinities between small molecules and proteins, critical for drug-target interaction studies.

Open Targets

Links genes, diseases, and drug interactions to enhance disease-target mapping.

Gene
Expression

Supplies transcriptomic data to analyze differential gene expressions related to diseases and treatments.

STRING
Database

Provides protein-protein interaction networks, helping in target validation for repurposed drugs.

Research Literature

Extracts knowledge from peer-reviewed scientific publications using NLP-based text mining.

Kyoto Encyclopedia

Maps pathways to understand drug-induced biological responses.

Our Process

A Seamless AI-Driven Drug Discovery Workflow

01
Data Ingestion & Curation

Data Ingestion & Curation

Comprehensive collection and standardization of biological data from multiple sources

02
Target-Based & Reverse Docking

Target-Based & Reverse Docking

Advanced computational screening using AI-powered docking algorithms

03
Post-Docking Refinement

Post-Docking Refinement

Sophisticated analysis and optimization of docking results

04
FEP Simulations

FEP Simulations

Precise binding affinity predictions using molecular dynamics

05
Report Generation

Report Generation

Detailed analysis and visualization of results

Key Applications

Transforming Drug Repurposing Across Therapeutic Areas

Oncology

Oncology

Identify new drug candidates for tumor suppression and immune modulation

Target Identification
Pathway Analysis
Biomarker Discovery
Infectious Diseases

Infectious Diseases

Discover antiviral and antibacterial applications for known compounds

Broad-Spectrum Activity
Resistance Analysis
Combination Therapy
Rare Diseases

Rare Diseases

Find alternative therapies for under-researched conditions

Novel Mechanisms
Patient Stratification
Orphan Indications
Neurological Disorders

Neurological Disorders

Repurpose existing drugs for neurodegenerative disease interventions

Blood-Brain Barrier
Target Validation
Bioavailability

Our Advanced Platform

Discover our platform's capabilities with advanced features that drive efficiency & accelerate drug discovery

Slide 1
Slide 2
Slide 3
Slide 4
Slide 5
Slide 6
Slide 7
Slide 8
Slide 9
Slide 10
Slide 11
Slide 12

Contact Us For Demo

Click the button below to get started—fill out the form now!

Why Medvolt

Accelerate Discovery

Medvolt's AI-powered platform cuts pre-clinical discovery time by 3x, reduces costs by 15x and lowers failure risk by 25%. Enhance your R&D efficiency with our in silico tools.

High-Throughput Data

Enrich your research with Medvolt's proprietary, gold-standard, high-throughput proprietary datasets. Our AI and NLP solutions deliver speed, precision and scalability.

Expert Collaboration

Our experienced, tech-driven team collaborates globally with leading pharma and biotech companies, ensuring impactful, scalable solutions.